Dulce M. Barrios - Publications

DESTINY-Gastric05 phase III trial of first-line trastuzumab deruxtecan, chemotherapy, and pembrolizumab in HER2-positive gastric or gastroesophageal junction cancer.

Journal: ESMO gastrointestinal oncology

Published: April 17, 2026

Analgesia and Anesthesia Practice Patterns for Gynecologic Brachytherapy Procedures and Potential Impact on Women's Procedural Experience: A National Survey.

Journal: International journal of radiation oncology, biology, physics

Published: March 05, 2024

Acute Febrile Neutrophilic Dermatosis (Sweet Syndrome) in Acute Myeloid Leukemia Patients: A 28-Year Institutional Experience.

Journal: Acta haematologica

Published: January 23, 2023

Metabolic syndrome is independently associated with improved overall survival to first-line therapy with immune checkpoint inhibitors in non-small cell lung cancer.

Journal: Frontiers in oncology

Published: December 30, 2022

Suggested methodology for longitudinal evaluation of nevi based on clinical images.

Journal: Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)

Published: April 04, 2021

Dermatologic infections in cancer patients treated with checkpoint inhibitors.

Journal: Journal of the American Academy of Dermatology

Published: July 24, 2020

IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: April 25, 2020

Immune checkpoint inhibitors to treat cutaneous malignancies.

Journal: Journal of the American Academy of Dermatology

Published: January 28, 2020

Immune checkpoint inhibitor-related dermatologic adverse events.

Journal: Journal of the American Academy of Dermatology

Published: January 28, 2020

Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer.

Journal: Breast cancer research and treatment

Published: January 10, 2020

Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: June 13, 2019

Bone Fractures in Children With Cholestatic Liver Disease May Mimic Those Seen in Child Abuse.

Journal: Pediatric emergency care

Published: January 24, 2019